Medicare Price Negotiation Will Continue Under Trump With Possible ‘Improvements’

HHS Secretary nominee Robert F. Kennedy Jr. discussed the Trump Administration's support for Medicare price negotiation during his confirmation hearing.

Robert F. Kennedy Jr. testifies as US Senate Finance Committee
Robert F. Kennedy Jr. showed an interest in narrowing the difference between US prices and those in other countries. (Screenshot Of Senate Finance Committee Broadcast)
Key Takeaways
  • The Trump Administration will continue the second cycle of the Medicare price negotiation program, but wants to increase transparency and make other potential "improvements" to the process.

The Trump Administration will continue the second cycle of Medicare price negotiations, which includes 15 drugs selected by the Biden...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Drug Pricing

More from Business